Affiliation: | a Institut für Biochemie der Charité, Humboldt-Universität, Medizinische Fakultät (Charité), Med. Universitätsklinik III, Schumannstr. 20 / 21, D-10117, Berlin, Germany b Gesellschaft für Biotechnologische Forschung mbH, Braunschweig, Germany c Institut für Medizinische Immunologie der Charité, Humboldt-Universität, Berlin, Germany |
Abstract: | An expression system has been established in Escherichia coli to facilitate the preparation of the HIV-1 capsid protein in amounts sufficient for structural analysis. A plasmid vector pTCA5, containing the gene for the recombinant HIV-1 capsid protein rp24 under the control of the λ-PR-promoter, was constructed which gave an expression product that spanned 234 amino acid residues. It differs at the N-terminus from the authentic sequence in that the residues Pro-Ile- are replaced by Met-Asn-Ser-Ala-Met-. Recombinant p24 was produced, as inclusion bodies in E. coli LE392 containing pTCA5, at a level of approximately 15% of the total cellular protein. After dissolution of the inclusion bodies in the acidic urea system, the protein was easily reconstituted in a soluble state by dialysis. The yield of reconstituted and purified protein was 12 mg per liter in rich medium. Recombinant rp24 consists of about 40% -helix and 10% β-sheet from circular dichroism measurements and the two cysteine residues, within the rp24 sequence, are bridged by a disulfide bond. |